A BILL 
To restrict the use of Federal Funds for gain-of-function 
research in the People’s Republic of China. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Fairness and Account-
4
ability in Underwriting Chinese Institutions Act’’ or the 
5
‘‘FAUCI Act’’. 
6
06:43 Nov 17, 2021
H5988
2 
•HR 5988 IH
SEC. 2. RESTRICTIONS ON FEDERAL FUNDING OF CERTAIN 
1
GAIN-OF-FUNCTION RESEARCH. 
2
(a) GAIN-OF-FUNCTION RESEARCH DEFINITION.—In 
3
this section, the term ‘‘gain-of-function research’’ means 
4
any research that— 
5
(1) may be reasonably anticipated to confer at-
6
tributes to influenza, MERS, or SARS viruses such 
7
that the virus would have enhanced pathogenicity or 
8
transmissibility in any organism; or 
9
(2) involves the enhancement of potential pan-
10
demic pathogens or related risky research with po-
11
tentially dangerous pathogens. 
12
(b) FUNDING LIMITATIONS.— 
13
(1) IN GENERAL.—Notwithstanding any other 
14
provision of law, no Federal funding may be made 
15
available for any purpose, including under any con-
16
tract, grant, subgrant, or other assistance, to labora-
17
tories or research institutions in the People’s Repub-
18
lic of China for the purposes of gain-of-function re-
19
search. 
20
(2) CERTIFICATION.—Any recipient of Federal 
21
funding for the purposes of scientific research shall 
22
certify to the issuing authority that such recipient 
23
will not distribute any such Federal funds, whether 
24
directly or through subgrants, to any qualifying lab-
25
oratory or research institution that is in the People’s 
26
06:43 Nov 17, 2021
H5988
3 
•HR 5988 IH
Republic of China or that receives any funding from 
1
the People’s Republic of China, for the purposes of 
2
gain-of-function research. 
3
(c) PENALTY FOR LACK OF CANDOR.—With respect 
4
to any official or employee of the National Institutes of 
5
Health, or grantee or employee or contractor of a grantee 
6
of the National Institutes of Health, who is determined 
7
by the Inspector General of the Department of Health and 
8
Human Services to have intentionally misled, or omitted 
9
information in a disclosure to, Congress, the National In-
10
stitutes of Health, or any relevant Inspector General about 
11
the direction, scope, or extent of Federal funding of inter-
12
national gain-of-function research, in addition to being 
13
subject to all other applicable criminal penalties— 
14
(1) such person shall not be eligible for any new 
15
Federal grant or other funding; 
16
(2) if such person previously received a Federal 
17
grant or other funding, such grant or other funding 
18
shall be immediately terminated and any unexpended 
19
funds shall be rescinded; and 
20
(3) such person shall not be eligible for Federal 
21
employment. 
22
(d) REPORT REQUIRED.—Not later than 30 months 
23
after the date of enactment of this Act, the Office of 
24
Science and Technology Policy, in consultation with the 
25
06:43 Nov 17, 2021
H5988
4 
•HR 5988 IH
Department of Health and Human Services, the Depart-
1
ment of Homeland Security, the Department of Justice, 
2
the Director of National Intelligence, and the Department 
3
of State, shall submit, in both classified and unclassified 
4
forms, a report to the appropriate committees of Congress 
5
providing an assessment of— 
6
(1) the United States capacity to determine the 
7
extent of gain-of-function research conducted by any 
8
laboratories of research institutions in the People’s 
9
Republic of China, including the Wuhan Institute of 
10
Virology, and safety protocols followed by labora-
11
tories or research institutions in the People’s Repub-
12
lic of China, including the Wuhan Institute of Virol-
13
ogy, in conducting any gain-of-function research; 
14
(2) the United States capacity to determine 
15
whether cooperation or relationships between labora-
16
tories or research facilities in the People’s Republic 
17
of China conducting gain-of-function research and 
18
the People’s Liberation Army exist; 
19
(3) costs and potential risks or benefits of any 
20
United States cooperation or funding with labora-
21
tories or research facilities in the People’s Republic 
22
of China conducting gain-of-function research; 
23
(4) a recommendation of whether the United 
24
States should resume or continue to suspend any co-
25
02:21 Nov 18, 2021
H5988
5 
•HR 5988 IH
operation or funding of laboratories or research fa-
1
cilities in the People’s Republic of China conducting 
2
gain-of-function research; 
3
(5) a list of all gain-of-function research cur-
4
rently being funded with financial support of any 
5
agency of the Federal Government, including the 
6
purpose, cost, pathogens, and location of research; 
7
(6) a detailed list of all Federal funding for re-
8
search being conducted in or with the People’s Re-
9
public of China; and 
10
(7) a determination of whether the Chinese lab-
11
oratories identified in the report have had, or con-
12
tinue to have, a connection to the proliferation of 
13
fentanyl and fentanyl-analogues in the United 
14
States. 
15
(e) NATIONAL SECURITY WAIVER.—The President 
16
may waive the limitation under subsection (b) with respect 
17
to particular research described in such subsection upon 
18
a determination that such a waiver would be in the na-
19
tional security interest. Such waiver shall be made publicly 
20
available at the time of its issuance. 
21
Æ 
02:21 Nov 18, 2021
H5988
